Products for Research Use Only
RegisterLogin

KSPWFTTL

CAT: 0804-HY-P3333-01Size: 5 mgDry Ice: NoHazardous: No
Product image 1
1 / 1
CAT#:0804-HY-P3333-01Size:5 mg
Selected
24/48H Stock Items & 2 to 6 Weeks non Stock Items.
Quick Request Actions
Description
KSPWFTTL is an immunodominant Kb-restricted epitope from the p15E transmembrane protein. KSPWFTTL can restore susceptibility of a tumor line to anti-AKR/Gross MuLV cytotoxic T lymphocytes[1][2].
CAS Number
153049-05-9
UNSPSC
12352209
Target
MHC
Type
Peptides
Related Pathways
Immunology/Inflammation
Applications
COVID-19-anti-virus
Field of Research
Cancer; Inflammation/Immunology
Assay Protocol
https://www.medchemexpress.com/kspwfttl.html
Purity
99.60
Solubility
H2O : 100 mg/mL (ultrasonic)
Smiles
O=C([C@H]1N(CCC1)C([C@H](CO)NC([C@@H](N)CCCCN)=O)=O)N[C@H](C(N[C@H](C(N[C@@H]([C@H](O)C)C(N[C@@H]([C@H](O)C)C(N[C@H](C(O)=O)CC(C)C)=O)=O)=O)CC2=CC=CC=C2)=O)CC3=CNC4=CC=CC=C34
Molecular Formula
C48H70N10O12
Molecular Weight
979.13
References & Citations
[1]White HD, et, al. An immunodominant Kb-restricted peptide from the p15E transmembrane protein of endogenous ecotropic murine leukemia virus (MuLV) AKR623 that restores susceptibility of a tumor line to anti-AKR/Gross MuLV cytotoxic T lymphocytes. J Virol. 1994 Feb;68 (2) :897-904.|[2]Rich RF, et, al. Antiretroviral cytolytic T-lymphocyte nonresponsiveness: FasL/Fas-mediated inhibition of CD4 (+) and CD8 (+) antiviral T cells by viral antigen-positive veto cells. J Virol. 1999 May;73 (5) :3826-34.
Shipping Conditions
Blue Ice
Storage Conditions
-80°C, 2 years; -20°C, 1 year (Powder, sealed storage, away from moisture)
Scientific Category
Peptides
Clinical Information
No Development Reported

Alternative Products

CatalogName
GTR19029975KSPWFTTL
PP44136-01H-KSPWFTTL-OH

Popular Products